FDA Inspection 1106250 — Pedro R. Fabian Calella, MD
The FDA completed an inspection of Pedro R. Fabian Calella, MD on September 26, 2019 in Godoy Cruz. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 26, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Godoy Cruz (Argentina)
Additional Details
Clinical Investigator (CI)